CeptarisCeptaris CompanyCeptaris Investigational DrugCeptaris NewsCeptaris Contact Us  
       
       
   
   
     
  Overview  
  Management  
  Board of Directors  
  Investors  
     


 


 


 


 

 


Vivo Ventures
Palo Alto Investors
Burrill & Company
Biotechnology Greenhouse of Southeastern Pennsylvania (“Bioadvance”)
Osage Ventures
Aperture Venture Partners


Vivo Ventures

Vivo Ventures is a life-sciences focused venture capital firm formed in 1996 with over $650 million under management. Vivo Ventures is currently making investments from its $275 million sixth fund into promising biotechnology and life science companies. With over 90 years of scientific and operational expertise in biotechnology, Vivo makes investment decisions for the Funds and helps its portfolio companies develop corporate strategy, arrange licensing agreements and strategic alliances, recruit key management personnel, and acquire new products and technology to accelerate growth. Its current portfolio includes more than 60 private and public biotechnology companies in the areas of biopharmaceuticals, specialty pharmaceuticals, and medical devices.
vivoventures.com

Palo Alto Investors

Palo Alto Investors, LLC (located in Palo Alto, California) is a registered investment advisor providing investment advisory services to a variety of investors including individuals, trusts, foundations and institutions. The firm currently manages over $1.6 billion in assets with an emphasis on Micro Cap and Small Cap market segments as well as the Healthcare, Energy and Technology sectors.
pa-investors.com

Burrill & Company

Burrill & Company is a life sciences merchant bank focused exclusively on companies involved in biotechnology, pharmaceuticals, diagnostics, devices, human healthcare and related medical technologies, nutraceuticals and wellness, agricultural biotechnology, and industrial biotechnology (biomaterials/bioprocesses) with over $950 million under management.
burrillandco.com 

Biotechnology Greenhouse of Southeastern Pennsylvania (“Bioadvance”)

BioAdvance is a venture fund founded with $33.8 million from tobacco settlement monies to grow the life sciences industry in Southeastern Pennsylvania. To fulfill its mission, BioAdvance invests in emerging life sciences technologies with the most promising commercialization prospects.
bioadvance.com

Osage Ventures

Osage Ventures is a venture capital fund that seeks to invest in determined and creative entrepreneurs that have a unique concept or product. Osage works closely to mentor entrepreneurs and assists them in building businesses from ideas. Building value is of primary importance to Osage, and we will invest the necessary time and capital to grow a business, irrespective of the future exit date. To date, Osage has seeded companies across a broad range of industries, many of which became publicly traded entities.
osageventures.com

Aperture Venture Partners

Aperture Venture Partners is a venture capital group committed to working with exceptional entrepreneurs to tackle significant problems and create major new opportunities. We work exclusively within the dynamic and growing healthcare industry. Our principals have been entrepreneurial leaders in the healthcare and investment industries over the past 30 years. They have successfully invested more than $1 billion and founded companies that have had combined revenues greater than $2 billion.
www.aperturevp.com

 
   
     
 
   
   
   
   
         
print page